Format

Send to

Choose Destination
J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.

Author information

1
Medical Sciences Institute & Blood Research Institute, Versiti & Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.
2
Department of Medicine, Seattle Cancer Care Alliance & University of Washington, Seattle, Washington.
3
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
4
Department of Medicine, University of Virginia, Charlottesville, Virginia.
5
Apheresis Research Institute, Cologne, Germany & First Department of Internal Medicine, University of Mainz, Mainz, Germany.
6
Department of Hematology/Oncology/BMT/Pathology, Nationwide Children's Hospital, Columbus, Ohio.
7
Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California.
8
Department of Pediatric Hematology/Oncology/Neuro-oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois.
9
Department for Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
10
Bloodworks NW & Department of Laboratory Medicine, University of Washington, Seattle, Washington, Yale University School of Medicine, New Haven, Connecticut.
11
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
12
Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
13
Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York.

Abstract

The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.

PMID:
31180581
DOI:
10.1002/jca.21705

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center